163 related articles for article (PubMed ID: 35121274)
1. Comparing the efficacy of pharmacological and psychological treatment, alone and in combination, in children and adolescents with obsessive-compulsive disorder: A network meta-analysis.
Tao Y; Li H; Li L; Zhang H; Xu H; Zhang H; Zou S; Deng F; Huang L; Wang Y; Wang X; Tang X; Fu X; Yin L
J Psychiatr Res; 2022 Apr; 148():95-102. PubMed ID: 35121274
[TBL] [Abstract][Full Text] [Related]
2. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Pediatric OCD Treatment Study (POTS) Team
JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults.
Skapinakis P; Caldwell D; Hollingworth W; Bryden P; Fineberg N; Salkovskis P; Welton N; Baxter H; Kessler D; Churchill R; Lewis G
Health Technol Assess; 2016 Jun; 20(43):1-392. PubMed ID: 27306503
[TBL] [Abstract][Full Text] [Related]
4. Comparison of internet-based and face-to-face cognitive behavioral therapy for obsessive-compulsive disorder: A systematic review and network meta-analysis.
Zhang W; Yang W; Ruan H; Gao J; Wang Z
J Psychiatr Res; 2023 Dec; 168():140-148. PubMed ID: 37907037
[TBL] [Abstract][Full Text] [Related]
5. Defining cognitive-behavior therapy response and remission in pediatric OCD: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.
Skarphedinsson G; De Nadai AS; Storch EA; Lewin AB; Ivarsson T
Eur Child Adolesc Psychiatry; 2017 Jan; 26(1):47-55. PubMed ID: 27209422
[TBL] [Abstract][Full Text] [Related]
6. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
March JS; Biederman J; Wolkow R; Safferman A; Mardekian J; Cook EH; Cutler NR; Dominguez R; Ferguson J; Muller B; Riesenberg R; Rosenthal M; Sallee FR; Wagner KD; Steiner H
JAMA; 1998 Nov; 280(20):1752-6. PubMed ID: 9842950
[TBL] [Abstract][Full Text] [Related]
7. [The clinical assessment of obsessive-compulsive symptoms in children and adolescents - A study with the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS-D)].
Goletz H; Döpfner M
Z Kinder Jugendpsychiatr Psychother; 2020; 48(3):178-193. PubMed ID: 30556768
[TBL] [Abstract][Full Text] [Related]
8. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E
Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830
[TBL] [Abstract][Full Text] [Related]
9. The children's Yale-Brown obsessive-compulsive scale: psychometric properties of child- and parent-report formats.
Storch EA; Murphy TK; Adkins JW; Lewin AB; Geffken GR; Johns NB; Jann KE; Goodman WK
J Anxiety Disord; 2006; 20(8):1055-70. PubMed ID: 16503111
[TBL] [Abstract][Full Text] [Related]
10. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
[TBL] [Abstract][Full Text] [Related]
11. One-Year Outcome for Responders of Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder.
Højgaard DRMA; Hybel KA; Ivarsson T; Skarphedinsson G; Becker Nissen J; Weidle B; Melin K; Torp NC; Valderhaug R; Dahl K; Mortensen EL; Compton S; Jensen S; Lenhard F; Thomsen PH
J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):940-947.e1. PubMed ID: 29096776
[TBL] [Abstract][Full Text] [Related]
12. Remission and Relapse Across Three Years in Pediatric Obsessive-Compulsive Disorder Following Evidence-Based Treatments.
Ivarsson T; Jensen S; Højgaard DRMA; Hybel KA; Torp NC; Melin K; Nissen JB; Weidle B; Thomsen PH; Dahl K; Skarphedinsson G
J Am Acad Child Adolesc Psychiatry; 2024 May; 63(5):519-527. PubMed ID: 38070870
[TBL] [Abstract][Full Text] [Related]
13. What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analysis.
Mendez EM; Dahlsgaard KK; Hjelmgren JM; Mills JA; Suresh V; Strawn JR
J Child Adolesc Psychopharmacol; 2023 Aug; 33(6):203-211. PubMed ID: 37347947
[No Abstract] [Full Text] [Related]
14. Treatment Gains Are Sustainable in Pediatric Obsessive-Compulsive Disorder: Three-Year Follow-Up From the NordLOTS.
Melin K; Skarphedinsson G; Thomsen PH; Weidle B; Torp NC; Valderhaug R; Højgaard DRMA; Hybel KA; Nissen JB; Jensen S; Dahl K; Skärsäter I; Haugland BS; Ivarsson T
J Am Acad Child Adolesc Psychiatry; 2020 Feb; 59(2):244-253. PubMed ID: 30768383
[TBL] [Abstract][Full Text] [Related]
15. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
[TBL] [Abstract][Full Text] [Related]
16. Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.
Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Dahl K; Nissen JB; Torp NC; Hybel K; Melin KH; Valderhaug R; Wentzel-Larsen T; Ivarsson T
J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):432-9. PubMed ID: 26091197
[TBL] [Abstract][Full Text] [Related]
17. Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting.
Yucelen AG; Rodopman-Arman A; Topcuoglu V; Yazgan MY; Fisek G
Compr Psychiatry; 2006; 47(1):48-53. PubMed ID: 16324902
[TBL] [Abstract][Full Text] [Related]
18. Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder.
Skarphedinsson G; Weidle B; Ivarsson T
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):574-9. PubMed ID: 26348088
[TBL] [Abstract][Full Text] [Related]
19. N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study.
Li F; Welling MC; Johnson JA; Coughlin C; Mulqueen J; Jakubovski E; Coury S; Landeros-Weisenberger A; Bloch MH
J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):32-37. PubMed ID: 31800306
[No Abstract] [Full Text] [Related]
20. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder.
Storch EA; Bussing R; Small BJ; Geffken GR; McNamara JP; Rahman O; Lewin AB; Garvan CS; Goodman WK; Murphy TK
Behav Res Ther; 2013 Dec; 51(12):823-9. PubMed ID: 24184429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
